Laurence Turka

Corporate Officer/Principal chez Immune Tolerance Network

Profil

Laurence Turka is the founder of Rheos Medicines, Inc. which was founded in 2018.
He is currently the Deputy Director at Immune Tolerance Network.
He is also a Member of the Association of American Physicians since 2003 and a Member of the American Society for Clinical Investigation since 1995.
Dr. Turka has held several former positions including Chairman-Scientific Counselors at the National Institute of Allergy & Infectious Diseases, President at The American Society of Transplantation, Professor at Harvard Medical School, and Editor in Chief at The Journal of Clinical Investigation.
Dr. Turka received his doctorate degree from Yale School of Medicine.
Additionally, Dr. Turka was the Chief Scientific Officer & Head-Research at Rubius Therapeutics, Inc. from 2021 to 2023.

Postes actifs de Laurence Turka

Sociétés	Poste	Début
Immune Tolerance Network	Corporate Officer/Principal	-
American Society for Clinical Investigation	Corporate Officer/Principal	01/01/1995
Association of American Physicians	Corporate Officer/Principal	01/01/2003

Anciens postes connus de Laurence Turka

Sociétés	Poste	Fin
RUBIUS THERAPEUTICS	Directeur Technique/Scientifique/R&D	31/01/2023
Rheos Medicines, Inc.	Fondateur	01/01/2020
National Institute of Allergy & Infectious Diseases	Corporate Officer/Principal	-
The Journal of Clinical Investigation	Corporate Officer/Principal	-
The American Society of Transplantation	President	-